Prudential Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$80.2M Buy
180,236
+11,381
+7% +$5.07M 0.1% 168
2025
Q1
$81.9M Buy
168,855
+717
+0.4% +$348K 0.12% 151
2024
Q4
$67.7M Sell
168,138
-42,095
-20% -$17M 0.09% 171
2024
Q3
$97.8M Sell
210,233
-79,409
-27% -$36.9M 0.14% 139
2024
Q2
$136M Buy
289,642
+34,181
+13% +$16M 0.2% 93
2024
Q1
$107M Buy
255,461
+4,642
+2% +$1.94M 0.15% 129
2023
Q4
$99.6M Sell
250,819
-53,122
-17% -$21.1M 0.15% 131
2023
Q3
$106M Sell
303,941
-170,512
-36% -$59.4M 0.17% 124
2023
Q2
$167M Sell
474,453
-59,395
-11% -$20.9M 0.24% 75
2023
Q1
$168M Sell
533,848
-146,638
-22% -$46.2M 0.26% 74
2022
Q4
$197M Sell
680,486
-38,436
-5% -$11.1M 0.33% 65
2022
Q3
$208M Buy
718,922
+13,296
+2% +$3.85M 0.35% 56
2022
Q2
$199M Sell
705,626
-43,229
-6% -$12.2M 0.32% 65
2022
Q1
$195M Buy
748,855
+88,350
+13% +$23.1M 0.26% 74
2021
Q4
$145M Buy
660,505
+49,727
+8% +$10.9M 0.18% 122
2021
Q3
$114M Buy
610,778
+177,000
+41% +$33.1M 0.16% 139
2021
Q2
$87.5M Buy
433,778
+140,680
+48% +$28.4M 0.12% 171
2021
Q1
$63M Sell
293,098
-198,252
-40% -$42.6M 0.09% 207
2020
Q4
$116M Sell
491,350
-17,532
-3% -$4.14M 0.2% 109
2020
Q3
$138M Sell
508,882
-210,505
-29% -$57.3M 0.26% 86
2020
Q2
$209M Sell
719,387
-28,493
-4% -$8.27M 0.4% 51
2020
Q1
$178M Buy
747,880
+126,226
+20% +$30M 0.39% 51
2019
Q4
$136M Sell
621,654
-75,480
-11% -$16.5M 0.2% 113
2019
Q3
$118M Buy
697,134
+60,438
+9% +$10.2M 0.19% 115
2019
Q2
$117M Buy
636,696
+111,567
+21% +$20.5M 0.18% 114
2019
Q1
$96.6M Buy
525,129
+196,761
+60% +$36.2M 0.16% 132
2018
Q4
$54.4M Sell
328,368
-577,159
-64% -$95.6M 0.1% 207
2018
Q3
$175M Buy
905,527
+593,667
+190% +$114M 0.26% 84
2018
Q2
$53M Buy
311,860
+32,535
+12% +$5.53M 0.08% 273
2018
Q1
$45.5M Sell
279,325
-67,930
-20% -$11.1M 0.07% 316
2017
Q4
$52M Buy
347,255
+670
+0.2% +$100K 0.07% 309
2017
Q3
$52.7M Sell
346,585
-98,140
-22% -$14.9M 0.08% 293
2017
Q2
$57.3M Buy
444,725
+50,350
+13% +$6.49M 0.09% 265
2017
Q1
$43.1M Sell
394,375
-158,130
-29% -$17.3M 0.07% 314
2016
Q4
$40.7M Sell
552,505
-73,980
-12% -$5.45M 0.07% 326
2016
Q3
$54.6M Buy
626,485
+106,808
+21% +$9.31M 0.09% 238
2016
Q2
$44.7M Buy
519,677
+23,460
+5% +$2.02M 0.08% 274
2016
Q1
$39.4M Buy
496,217
+185,800
+60% +$14.8M 0.07% 283
2015
Q4
$39.1M Buy
310,417
+7,670
+3% +$965K 0.07% 286
2015
Q3
$31.5M Sell
302,747
-9,090
-3% -$947K 0.06% 330
2015
Q2
$38.5M Sell
311,837
-1,300
-0.4% -$161K 0.07% 309
2015
Q1
$36.9M Buy
313,137
+4,290
+1% +$506K 0.06% 336
2014
Q4
$36.7M Sell
308,847
-5,780
-2% -$687K 0.07% 312
2014
Q3
$35.3M Sell
314,627
-30,537
-9% -$3.43M 0.07% 307
2014
Q2
$32.7M Buy
345,164
+15,757
+5% +$1.49M 0.06% 330
2014
Q1
$23.3M Buy
329,407
+41,300
+14% +$2.92M 0.04% 427
2013
Q4
$21.4M Sell
288,107
-196,800
-41% -$14.6M 0.04% 432
2013
Q3
$36.8M Buy
484,907
+186,447
+62% +$14.1M 0.08% 256
2013
Q2
$23.8M Buy
+298,460
New +$23.8M 0.05% 359